TransWeb, LLC v. 3M Innovative Properties Co.
16 F. Supp. 3d 385
D.N.J.2014Background
- TransWeb, a small filtration‑media company, developed and publicly distributed a plasma‑fluorinated meltblown polypropylene electret web (T‑Melt) in 1997; 3M later filed patents (U.S. Pat. Nos. 6,397,458 and 6,808,551) claiming related fluorination methods and uses (filed 1998).
- TransWeb sued for declaratory relief (invalidity, inequitable conduct, noninfringement) and antitrust (Walker Process fraud, sham litigation); 3M counterclaimed for patent infringement but narrowed claims before trial to two claims of the '458 patent.
- At trial a jury found the asserted 3M claims invalid as obvious, found Walker Process fraud, found no infringement by TransWeb, and returned a unanimous advisory verdict of inequitable conduct; the jury awarded TransWeb lost profits and attorneys’ fees as antitrust damages.
- The Court reviewed post‑trial Rule 50 motions and conducted a de novo review of inequitable conduct, finding by clear and convincing evidence that 3M inventors and in‑house counsel knowingly withheld and misrepresented material prior art (TransWeb’s public distribution at the 1997 Minneapolis Expo and related samples) to the PTO, rendering the patents unenforceable.
- The Court upheld the jury’s Walker Process verdict as supported by evidence that (1) the undisclosed prior art was but‑for material, (2) 3M had knowledge of and specific intent to deceive the examiner, and (3) TransWeb demonstrated relevant product and geographic markets and a dangerous probability of monopoly; it denied 3M’s JMOL on those counts.
- A Special Master’s allocation and calculation of TransWeb’s attorneys’ fees and costs (total ≈ $26.1M, with patent‑defense fees trebled where appropriate) was sustained by the Court after objections and review.
Issues
| Issue | TransWeb's Argument | 3M's Argument | Held |
|---|---|---|---|
| Validity (obviousness / prior art public use) | T‑Melt samples were publicly distributed at the 1997 Minneapolis Expo and were prior art that, combined with Angadjivand, rendered 3M’s claims obvious | Evidence of Expo distribution was insufficient (reliant on Ogale), samples were confidential or not prior art | Court refused JMOL for 3M: jury reasonably could find corroborating documentary and physical evidence established public use and that the method could be determined from samples; verdict of invalidity stands |
| Inequitable conduct (duty to disclose) | 3M knowingly withheld material prior art (Expo samples, Willson respirator, PTX‑1338) and misled the examiner about confidentiality to overcome rejection | 3M argued no intent to deceive, inadvertent non‑disclosure, and that disclosed Racal samples sufficed | Court found by clear and convincing evidence that inventors and prosecutor (Jones, Hanson) acted with specific intent to deceive; patents unenforceable |
| Walker Process antitrust (attempted monopolization) | Fraudulent procurement of patent and enforcement constituted antitrust injury; geographic and product markets (U.S., fluorinated polymeric media for respirators) supported danger of monopoly and damages (attorney fees) | Argued lack of proof of relevant market, market shares, anti‑competitive effects, and antitrust injury tied to fees | Court denied JMOL: sufficient evidence supported U.S. geographic market, distinct upstream/downstream markets, dangerous probability of monopoly, and that attorney fees flowed from anticompetitive conduct |
| Attorneys’ fees allocation and reasonableness | Special Master reasonably parsed mixed billing, assigned patent vs antitrust proportions, and applied trebling to patent defense fees; Quinn Emanuel rates justified | 3M argued mixed entries should be treated as antitrust (reducing trebling) and hourly rates were above market (requesting 20% discount) | Court affirmed Special Master’s detailed allocation and rate analysis; total award (~$26.1M) sustained |
Key Cases Cited
- Therasense, Inc. v. Becton, Dickinson & Co., 649 F.3d 1276 (Fed. Cir. 2011) (sets high standard for proving inequitable conduct: knowledge, materiality, and specific intent to deceive; but‑for materiality rule)
- Finnigan Corp. v. Int’l Trade Comm’n, 180 F.3d 1354 (Fed. Cir. 1999) (uncorroborated testimony of public use must be corroborated)
- Sandt Tech., Ltd. v. Resco Metal & Plastics Corp., 264 F.3d 1344 (Fed. Cir. 2001) (circumstantial or documentary corroboration of inventor testimony can suffice)
- Adenta GmbH v. OrthoArm, Inc., 501 F.3d 1364 (Fed. Cir. 2007) (corroboration questions turn to sufficiency of evidence; jury questions analyzed under rule of reason)
- W.L. Gore & Assocs., Inc. v. Garlock, Inc., 721 F.2d 1540 (Fed. Cir. 1983) (product on sale/public use is prior art only if public could determine the claimed process from the product)
- Lightning Lube, Inc. v. Witco Corp., 4 F.3d 1153 (3d Cir. 1993) (standard for Rule 50 judgment as a matter of law)
- Handgards, Inc. v. Ethicon, Inc., 601 F.2d 986 (9th Cir. 1979) (attorneys’ fees incurred defending a sham or bad‑faith prosecution can be recoverable antitrust damages)
- Multiflex, Inc. v. Samuel Moore & Co., 709 F.2d 980 (5th Cir. 1983) (attempted monopolization need not cause actual damage; dangerous probability suffices)